![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...
News
Optimus Pharma gets nod from DGCI to make COVID-19 drug ‘Favicovid’
Optimus Pharma said it has received the Drugs Controller General of India (DCGI) approval to manufacture and market Favipiravir 200 mg tablets for the...
Press Releases
DuPont Nutrition & Biosciences Announces Research Collaboration with Rutgers University
DuPont Nutrition & Biosciences (DuPont) announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University...
Drug Research
Seven Indian Drugmakers Race To Develop Covid-19 Vaccine
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E among domestic pharma firms working on the vaccines in India
At...
Packaging & Labelling
DHL in collaboration with R360 is supporting the Logistics Cluster in monitoring supply chains
Deutsche Post DHL Group (DPDHL) and Resilience360 are providing the Global Logistics Cluster, which is led by the United Nations World Food Programme (WFP),...
News
Dm-drogerie markt opens a new distribution center in Germany: with robotics & software from Swisslog
The first pallet leaving the center in Wustermark headed for our dm drugstores marks a milestone,” said Christoph Werner, Chairman of the dm Board,...
Clinical Trials
Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
